Genomic characterization of invasive meningococcal X isolates from Brazil, 1992–2022
Authors:
- Ana Paula CassiolatoACAna Paula Cassiolato
- Carlos Henrique CamargoCarlos Henrique Camargo
- Maria Cristina Piccoli CecconiMCMaria Cristina Piccoli Cecconi
- Sandra ChristakisSCSandra Christakis
- Claudia Regina GonçalvesCGClaudia Regina Gonçalves
- Karoline Rodrigues CamposKCKaroline Rodrigues Campos
- Fabio Takenori HigaFHFabio Takenori Higa
- Gabriela Andrade PereiraGPGabriela Andrade Pereira
- Camile de MoraesCMCamile de Moraes
- Ana Paula Silva de LemosALAna Paula Silva de Lemos
- 10 January 2023
- journal article
- research article
- Published by Springer Nature in International Microbiology
- Vol. 26 (3) , 611-618
Abstract
Introduction Invasive meningococcal disease (IMD) is a major health problem. Given the post-COVID-19 pandemic scenario with the loosening of the non-pharmacological measures to control the virus transmission and considering the observed global reduction of meningococcal vaccination coverage, an increase in IMD cases can be expected. Methodology Using whole-genome sequencing, we characterized six Neisseria meningitidis serogroup X (MenX) isolates recovered from IMD cases in Brazil in the last 30 years. Results The predominance (66.6%, 4/6) of ST2888 presenting fHbp 160, NHBA 129, NadA 21, and PorA 19,15 was found on isolates. Two novel STs, 15458 and 15477, were described. Conclusion This study describes the circulation of MenX lineage ST2888 in Brazil, previously reported only in Europe. Continuous universal surveillance is crucial to implement prompt public health measures aiming to prevent and control non-vaccine preventable serogroup X IMD cases.Keywords
This publication has 31 references indexed in Scilit:
- Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccineBMC Infectious Diseases, 2013
- Meningococcal disease: changes in epidemiology and preventionClinical Epidemiology, 2012
- The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigensVaccine, 2012
- Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina FasoPLOS ONE, 2011
- Neisseria meningitidisSerogroup X Sequence Type 2888, ItalyEmerging Infectious Diseases, 2010
- Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in NigerClinical Infectious Diseases, 2007
- Prospective Study of a Serogroup XNeisseria meningitidisOutbreak in Northern GhanaThe Journal of Infectious Diseases, 2002
- Population genetics and molecular epidemiology of Neisseria meningitidisAPMIS, 1998
- COMPLEMENT DEFICIENCIES IN PATIENTS OVER TEN YEARS OLD WITH MENINGOCOCCAL DISEASE DUE TO UNCOMMON SEROGROUPSThe Lancet, 1989
- Meningococcal disease in South Australia: incidence and serogroup distribution 1971–1980Epidemiology and Infection, 1983